Relmada Therapeutics earnings were -$86.5M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest RLMD earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$21.7M, up 22.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, RLMD reported annual earnings of -$98.8M, with -37.1% growth. The next RLMD earnings date is Mar 17, 2025.
Relmada Therapeutics Earnings Reports & History FAQ
What were Relmada Therapeutics's earnings last quarter?
On RLMD's earnings call on Invalid Date, Relmada Therapeutics (NASDAQ: RLMD) reported Q3 2024 earnings per share (EPS) of -$0.72, up 1.37% year over year. Total RLMD earnings for the quarter were -$21.73 million. In the same quarter last year, Relmada Therapeutics's earnings per share (EPS) was -$0.73.
The next RLMD earnings call is Invalid Date. Add RLMD to your watchlist to be reminded of Relmada Therapeutics's next earnings date.
What was RLMD's earnings growth in the past year?
As of Relmada Therapeutics's earnings date in Invalid Date, Relmada Therapeutics's earnings has grown year over year. RLMD earnings in the past year totalled -$86.49 million.
Is Relmada Therapeutics profitable or losing money?
As of the last Relmada Therapeutics earnings report, Relmada Therapeutics is currently losing money. Relmada Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$86.49 million, a 22.48% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.